ライフサイエンスコーパス: immunochemical

1 a positive result on a fecal test (guaiac or immunochemical).

2 Immunochemical analyses after pervanadate treatment show

3 Immunochemical analyses at embryonic days 5 and 14 revea

4 Biochemical and immunochemical analyses demonstrate that zebrafish Plin6

5 Genetic and immunochemical analyses indicate that p20 is dispensable

6 Immunochemical analyses indicated decreased binding of N

7 Immunochemical analyses indicated that ribose and glucos

8 tity of the target antigen was determined by immunochemical analyses of candidate antigens using the

9 Immunochemical analyses of protein expression and locali

10 Quantitative PCR and immunochemical analyses of the process preparation revea

11 Immunochemical analyses reveal that TSA blocks specific

12 Immunochemical analyses revealed a robust expression of

13 Mass spectrometric and immunochemical analyses showed that NTHi LOS contained t

14 Additionally, mass spectrometric and immunochemical analyses showed that the LOS from H. haem

15 tein sequencing, peptide fingerprinting, and immunochemical analyses were used to identify the four s

16 Based on mass spectrometry, knockdown, and immunochemical analyses, the proteoglycan contains two m

17 vironmental variability of wheat proteins on immunochemical analyses, which affects the choice of glu

18 been performed by using cysteine mapping and immunochemical analyses.

19 Immunochemical analysis demonstrates that CMF1 protein i

20 This immunochemical analysis has provided valuable insight in

21 g electrophysiological, tracer coupling, and immunochemical analysis in brain slices of rat and mouse

22 Immunochemical analysis indicated lower levels of both t

23 Previously, immunochemical analysis of a series of breast cancer cel

24 of Alzheimer's disease is currently based on immunochemical analysis of brain slices with the AT8 ant

25 Unexpectedly, immunochemical analysis of COS-7 cells transfected with

26 Immunochemical analysis of endogenous dynamin distributi

27 operties of the mutant ATPase and results of immunochemical analysis of F0 subunit polypeptides.

28 ined from these survivors provide a detailed immunochemical analysis of individual human solutions to

29 Immunochemical analysis of murine mammary tumors shows n

30 Using immunochemical analysis of protein samples extracted fro

31 , but a prior lack of antibodies has limited immunochemical analysis of the ST6Gal-I protein.

32 Immunochemical analysis revealed decreased expression le

33 Immunochemical analysis revealed the appearance or a not

34 Biochemical and immunochemical analysis showed that PFA0210c associates

35 Electron microscopy and immunochemical analysis showed that S-phase variants syn

36 Immunochemical analysis was performed for detecting foca

37 na thermophila using in vivo mutagenesis and immunochemical analysis with modification-specific antib

38 Immunochemical analysis with smooth muscle alpha-actin-s

39 Mass spectrometry, immunochemical analysis, and CRISPR editing identified a

40 Based on immunochemical analysis, Mn(II)-induced apoptosis does n

41 R) confirmed the results of light microscopy immunochemical analysis.

42 aphy and identified by mass spectrometry and immunochemical analysis.

43 t blood sampling coupled to expensive serial immunochemical analysis.

44 essed high levels of osteopontin as shown by immunochemical analysis.

45 the pH and buffering the sample prior to the immunochemical analysis.

46 first time with the aim to produce valuable immunochemical analytical assays.

47 With these antibodies, an immunochemical analytical procedure able to quantify bot

48 In this context, an immunochemical analytical protocol has been established

49 Using immunochemical and biochemical approaches, we show that

50 n was isolated from rat platelets, which had immunochemical and biochemical identity to plasma factor

51 chick also allowed us to merge histological, immunochemical and cell proliferation labelling studies

52 d its subcellular localization by the use of immunochemical and cellular fractionation techniques.

53 g quantitative polymerase chain reaction and immunochemical and confocal imaging analyses.

54 By use of immunochemical and cysteine residue modification techniq

55 ally to the amygdala and, as defined by both immunochemical and electrophysiological criteria, genera

56 Then, by combining live-cell imaging with immunochemical and genetic approaches, we report that VP

57 The immunochemical and genetic data identify the genes and p

58 of the stimuli used to model immune insults, immunochemical and hybridization histochemical methods w

59 t evidence on the identity of NFs in NFTs by immunochemical and mass spectrometric analysis.

60 generated and characterised using molecular, immunochemical and morphological techniques.

61 In terms of immunochemical and NADH dehydrogenase activity-staining

62 for identification of immunotypes defined by immunochemical and neutralization data generated with an

63 nly related to screening techniques based on immunochemical and physiochemical methods, whose major l

64 Though conventional immunochemical and polymerase chain reaction (PCR)-based

65 Previous immunochemical and surface plasmon resonance-based studi

66 In sum, combining MACS with immunochemical and transcriptomics approaches provides a

67 Immunochemical and ultrastructural studies showed dystro

68 sucrose did not change the electrophoretic, immunochemical, and lysine-binding properties of Lp(a) i

69 ssembly behavior of EtxB by electrophoretic, immunochemical, and spectroscopic techniques and compare

70 ron types, each with distinct morphological, immunochemical, and/or physiological properties.

71 nstant outperformed a monoclonal antibody in immunochemical applications.

72 tive abundance of cAMP, we developed a novel immunochemical approach based on acrolein fixation to vi

73 The development of a sensitive immunochemical approach reported here made it possible t

74 A novel immunochemical approach to diagnose Pseudomonas aerugino

75 In this study, an immunochemical approach was used to circumvent the insol

76 y offers significant advantages over current immunochemical approaches for monitoring Src activity.

77 In this study, we have used biochemical and immunochemical approaches to more critically assess the

78 combined use of insertional mutagenesis and immunochemical approaches to probe the structural determ

79 Using a combination of MS and immunochemical approaches we found that 5-15% of the AID

80 combined molecular genetic, biochemical, and immunochemical approaches, we demonstrate that WRN also

81 Using a combination of mass spectrometry and immunochemical approaches, we found that in addition to

82 ation of bacterial genetics, microscopy, and immunochemical approaches.

83 pal neurones, using electrophysiological and immunochemical approaches.

84 We have developed a lateral flow immunochemical assay for the measurement of DNase I acti

85 al sensor which employs a modification of an immunochemical assay format for the immobilization of no

86 upled to AuNP, on double and single-antibody immunochemical assay steps, respectively), in respect to

87 ods of measuring DNase I relies either on an immunochemical assay, which requires multiple washing st

88 ervical, thoracic and lumbar spinal cord for immunochemical assay.

89 cardial cytokine expression was evaluated by immunochemical assay.

90 y, thereby increasing the sensitivity of the immunochemical assay.

91 Immunochemical assays constitute complementary analytica

92 size can be a limitation for biochemical and immunochemical assays requiring protein extraction.

93 the outcome from the effect of the pH on the immunochemical assays suggests that the selectivity coul

94 Synchronous fluorescence (SF) and immunochemical assays were used to study glycation in vi

95 tes were studied by atomic force microscopy, immunochemical assays, fluorescence microscopy, and vibr

96 hus mimicking the function of an antibody in immunochemical assays.

97 ed nuclear cataracts were analyzed by SF and immunochemical assays.

98 d beads, which were subsequently employed in immunochemical bead flow assays.

99 Immunochemical, biochemical and pharmacological studies

100 e used in a newly developed thermal mediated immunochemical biosensing technique which involves the b

101 ess achieved during the recent five years in immunochemical biosensors (immunosensors) combined with

102 by multivariate analysis that included fecal immunochemical blood test.

103 f three model IC preparations with different immunochemical characteristics.

104 Immunochemical characterization has shown that the epito

105 This was accomplished by physicochemical and immunochemical characterization of the NC1 hexamers usin

106 Further immunochemical characterization was performed in mice wi

107 ding site was identified using an integrated immunochemical, chemical, and molecular modeling approac

108 linergic, calretinin, and nitrergic neuronal immunochemical codes in the myenteric plexus.

109 Force was applied to the immunochemical complex by labeling the secondary antibod

110 les but was not strong enough to rupture the immunochemical complex.

111 MS-based identification with immunochemical confirmation combined with gene ontology

112 This assay may serve as an important immunochemical correlate for inhibition of invasion.

113 Serum antibodies exhibited strong immunochemical cross-reactivity with V3 peptides from cl

114 Biochemical and immunochemical data from the present investigation revea

115 -phenylindole staining, suggesting, with the immunochemical data, a link between these organelles and

116 licated in Alzheimer's disease (AD) based on immunochemical detection of alpha1-antichymotrypsin (ACT

117 induced activation of PKD1, as determined by immunochemical detection of autophosphorylation.

118 Immunochemical detection of Fos protein was used as a me

119 ex in hematoxylin-eosin (HE) sections and by immunochemical detection of Ki67 nuclear antigen.

120 ration into hepatic DNA and mitotic index by immunochemical detection of Ki67) and 40 h (mitotic inde

121 ration into hepatic DNA and mitotic index by immunochemical detection of Ki67) and at 32 h (mitotic i

122 petitive RT-PCR measurements of PDS mRNA and immunochemical detection of PDS protein, we determined t

123 tilized two-dimensional gel electrophoresis, immunochemical detection of protein carbonyls, and mass

124 The present method, when combined with immunochemical detection of protein carbonyls, should be

125 gel electrophoresis (SDS-PAGE), followed by immunochemical detection.

126 n the present study we further characterized immunochemical distinctions among mouse inhibitory corti

127 We developed an immunochemical dot blot method for quantitation of prote

128 Histologic and immunochemical evidence of differentiation, as assessed

129 conclusions are based on pharmacological and immunochemical evidence, although these approaches are i

130 Fractionation and immunochemical experiments indicate that this novel conf

131 Immunochemical experiments showed that the patient and h

132 strategies: 1) No Screening, 2) FIT: annual immunochemical fecal occult blood test age 40-75 years,

133 We compared immunochemical findings with those from colonoscopy usin

134 Prompted by our recent immunochemical findings, we sought evidence for an assoc

135 n degree of positivity on guaiac FOBT and on immunochemical FOBT (p<0.003).

136 for colorectal cancer by use of a sensitive immunochemical FOBT could select more appropriately thos

137 Immunochemical FOBT for individuals with positive guaiac

138 two samples, each from separate stools, for immunochemical FOBT while awaiting colonoscopy.

139 tal cancer screening, we advocate the use of immunochemical FOBTs as the preferred screening strategy

140 testing, molecular model visualizations, and immunochemical identification of both proteins.

141 ion of novel autoantibody, the autoantigen's immunochemical identification, clinical and magnetic res

142 ould identify the nature of the influence of immunochemical interaction constants and reagent concent

143 ical device that still provides the two-step immunochemical interactions - formation of a complex of

144 Immunochemical labeling showed that MUC5AC was localized

145 mouse inhibitory cortical neurons by double immunochemical labeling with chemical markers.

146 This was confirmed by immunochemical labelling of berry sections using antibod

147 The immunochemical levels of KGDHC subunits Elk (-51%) and E

148 High-performance immunochemical mapping, image registration, and quantita

149 High-performance immunochemical mapping, image registration, and quantita

150 Quantitative immunochemical measurements showed that this reduction o

151 Here we report on the development of an immunochemical method for detecting sulfenic acid, the i

152 Immunochemical methods are highly deployed in analytical

153 Mass spectrometry and immunochemical methods demonstrate MPO-dependent formati

154 By using immunochemical methods in conjunction with cysteine-scan

155 Molecular and immunochemical methods were used to study ZNF804A messen

156 Detection of PrP(Sc) commonly relies on immunochemical methods, a strategy hampered by the lack

157 has been intensively studied using different immunochemical methods, but has never been analyzed in a

158 itation by MS also closely matched data from immunochemical methods.

159 DL) and of the LDL apoprotein as assessed by immunochemical methods.

160 iform structures can be detected by standard immunochemical methods.

161 eria content, and submitted to histological, immunochemical, molecular, and immunological analyses.

162 the surface modifications and the secondary immunochemical or enzyme-linked steps that are common in

163 The results demonstrate the potential of the immunochemical procedure reported here to rapidly screen

164 with the aim to develop rapid and practical immunochemical procedures for trifloxystrobin determinat

165 ulins according to their electrophoretic and immunochemical properties.

166 ted to a substrate, followed by quantitative immunochemical protein detection, known to be particular

167 After the immunochemical reaction, the CdSNP are dissolved and the

168 Accordingly, we asked whether distinct immunochemical reactions might occur after xenotransplan

169 r the rapid and accurate characterization of immunochemical reactions that forms part of screening pr

170 Once the immunochemical reactions took place on the magnetic bead

171 comparison of electrophoretic mobilities and immunochemical reactivities before and after neuraminida

172 Consequently, the immunochemical reactivities of 1,176 combinations of hum

173 ization-time of flight mass spectrometry and immunochemical reactivity using antibodies directed to 4

174 With recently developed immunochemical reagents, we confirm this interaction and

175 Ab response to this antigen and the lack of immunochemical reagents.

176 The biochemical and immunochemical results demonstrated that linkage specifi

177 In addition, the obtained immunochemical results with naturally contaminated sampl

178 An immunochemical screen revealed that polypeptides of 58 a

179 A rapid high-throughput immunochemical screening (HtiS) procedure for the analys

180 between stiff byssus and the soft tissue by immunochemical staining and confocal Raman imaging, impl

181 Phosphorylated opsin immunochemical staining and in vitro phosphorylation ass

182 Immunochemical staining demonstrates the distribution of

183 When methylation status was compared to immunochemical staining for E-Cadherin, we found signifi

184 expression and EBV presence was verified by immunochemical staining of EBV(+) and EBV(-) DLBCL, sugg

185 Immunochemical staining of human lung sections showed th

186 Immunochemical staining of liver sections indicated that

187 vo marker of perfused vessels, combined with immunochemical staining of PECAM-1 (CD31) as a marker of

188 Immunochemical staining of sentinel lymph nodes (SLNs) a

189 (70 days) and aged (200 days) adults, using immunochemical staining of the dendritic associated prot

190 Immunochemical staining of tissues from patients with MA

191 Immunochemical staining revealed colocalization of EGFR

192 Immunochemical staining revealed CRHR1 expression was ma

193 of TGF-beta protein was also compared using immunochemical staining technique, and circulating level

194 xpression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BC

195 be present prominently at the sperm head by immunochemical staining with its specific mAb kdn3G.

196 Immunochemical staining with polyclonal antibodies showe

197 e detectable in inguinal lymph nodes by dual immunochemical staining.

198 ine were used for genetic cell targeting and immunochemical staining.

199 cimens were sent to a central laboratory for immunochemical staining; treating clinicians were blinde

200 Affinity labeling and immunochemical studies characterized brucipain as the K1

201 Compositional and immunochemical studies demonstrated a zwitterionic charg

202 Immunochemical studies demonstrated high levels of A ant

203 presence of fusion pores, and immunoAFM, and immunochemical studies demonstrated t-SNAREs to localize

204 Immunochemical studies demonstrated that t-SNAREs, NSF,

205 Immunochemical studies detected cytochrome P450 LAomega

206 Immunochemical studies have shown that most of the mutan

207 Subcellular fractionation and immunochemical studies indicate that LOX-1 is naturally

208 Immunochemical studies indicate that the GP-COL-1 protei

209 Furthermore, immunochemical studies localized F329 in the FepA ligand

210 CCX modular arrangements was correlated with immunochemical studies of C4A and C4B protein polymorphi

211 against LanCL1 was generated and applied to immunochemical studies of spinal cord tissue from SOD1G9

212 a novel molecule, gp44, were observed during immunochemical studies on the expression of Qa-1b molecu

213 re of renal AA omega-hydroxylation kinetics, immunochemical studies revealed participation of two P45

214 nce from imaging, histological, genetic, and immunochemical studies support the involvement of axonal

215 -specific probes, followed by histologic and immunochemical studies using anticytokeratin (AE1/AE3) a

216 Immunochemical studies with OD1 indicated that antibody

217 ay, together with in vitro kinase assays and immunochemical studies, we report that p38 MAPK plays a

218 We have developed an immunochemical technique for the quantification of carbo

219 Using immunochemical techniques and high-performance liquid ch

220 The aim of this work was the development of immunochemical techniques based on recombinant antibodie

221 , three separate studies failed with various immunochemical techniques to detect AQP1 protein in adul

222 hes, it is compatible with histochemical and immunochemical techniques, as well as emerging molecular

223 based on either mass spectrometry (MS) or on immunochemical techniques, such as western blotting (WB)

224 ere studied during corneal development using immunochemical techniques: alpha 3 beta 1 integrin and a

225 noscopy after a positive result from a fecal immunochemical test (FIT cohort, n = 34,221) or undergoi

226 ary analyses were performed, including fecal immunochemical test (FIT) as an alternative test, earlie

227 ary analyses were performed, including fecal immunochemical test (FIT) as an alternative test, earlie

228 ficity, but at a higher cost, than the fecal immunochemical test (FIT) can be used in screening.

229 The fecal immunochemical test (FIT) for detecting hemoglobin is us

230 ive, multitarget stool DNA test with a fecal immunochemical test (FIT) in persons at average risk for

231 The fecal immunochemical test (FIT) is a common method for colorec

232 The fecal immunochemical test (FIT) is commonly used for colorecta

233 The fecal immunochemical test (FIT) is the second most commonly us

234 The fecal immunochemical test (FIT) is the tool most frequently us

235 Mailed fecal immunochemical test (FIT) outreach is more effective tha

236 capacity, it has been suggested that faecal immunochemical test (FIT) results could guide surveillan

237 tion in adults with abnormal screening fecal immunochemical test (FIT) results.

238 We performed a prospective study of fecal immunochemical test (FIT) screening among African Americ

239 Fecal immunochemical test (FIT) screening with colonoscopy sur

240 ne-time colonoscopy, sigmoidoscopy, or fecal immunochemical test (FIT) screening.

241 The fecal immunochemical test (FIT), as a direct measure of human

242 colonoscopy every 10 years and annual fecal immunochemical test (FIT).

243 f the 8 programs, screenings using the fecal immunochemical test annually and colonoscopy every 10 ye

244 come was sensitivity of a quantitative fecal immunochemical test at 2 predefined cutoffs (10.2 and 17

245 workup due to positive results from a fecal immunochemical test or signs or symptoms of CRC, at 3 ce

246 Among patients with a positive fecal immunochemical test result, compared with follow-up colo

247 on, fecal occult blood test cards, and fecal immunochemical test tubes).

248 on rates after abnormal results from a fecal immunochemical test yielded greater benefits and savings

249 was detected in the wines studied in either immunochemical test, irrespective of the physicochemical

250 s were found in any of the samples by either immunochemical test, irrespective of the physicochemical

251 iac-based fecal occult blood test, the fecal immunochemical test, the multitargeted stool DNA test, a

252 egy in organized programs involves the fecal immunochemical test, which is limited by low sensitivity

253 tive guaiac fecal occult blood test or fecal immunochemical test.

254 2 predefined cutoffs of a quantitative fecal immunochemical test.

255 1214) 2 days before fecal sampling for fecal immunochemical test.

256 he evidence supporting the use of both fecal immunochemical testing (FIT) and stool DNA (sDNA) has be

257 Colonoscopy and fecal immunochemical testing (FIT) are accepted strategies for

258 Primary colonoscopy and fecal immunochemical testing (FIT) are considered first-tier t

259 ive effectiveness of sigmoidoscopy and fecal immunochemical testing (FIT) for colorectal cancer (CRC)

260 Screening using fecal immunochemical testing (FIT) is effective in reducing mo

261 d fecal occult blood testing (FOBT) or fecal immunochemical testing (FIT), and no screening.

262 aiac-based fecal occult blood testing, fecal immunochemical testing (FIT), multitarget stool DNA test

263 occult blood testing (HSFOBT), annual fecal immunochemical testing (FIT), or computed tomographic co

264 t screening programs worldwide rely on fecal immunochemical testing (FIT).

265 ed after screening with colonoscopy or fecal immunochemical testing (FIT).

266 ning enhances patient participation in fecal immunochemical testing (FIT).

267 Current state-of-the-art method of Faecal Immunochemical Testing achieving sensitivity ~90%, unfor

268 Initiation of fecal immunochemical testing at age 45 years instead of 50 yea

269 ible sigmoidoscopy every 10 years plus fecal immunochemical testing every 2 years.

270 Fecal immunochemical testing exhibits some advantages over gua

271 Fecal immunochemical testing is the most commonly used method

272 sted screening tests and intervals are fecal immunochemical testing or high-sensitivity guaiac-based

273 ter, Fullerton, California) testing or fecal immunochemical testing, and sigmoidoscopy every 5 years

274 a single dose of oral aspirin prior to fecal immunochemical testing, compared with placebo, did not s

275 prostate-specific antigen testing, or fecal immunochemical testing.

276 The latest generation of fecal immunochemical tests (FIT) allows for quantitation of he

277 Fecal immunochemical tests (FIT) were additionally performed f

278 imited on how many persons screened by fecal immunochemical tests (FIT), over multiple rounds, develo

279 al to compare the efficacy of repeated fecal immunochemical tests (FITs) and colonoscopy in detecting

280 Faecal immunochemical tests (FITs) are commonly used in colorec

281 he most commonly evaluated families of fecal immunochemical tests (FITs) demonstrated good sensitivit

282 ies report inconsistent performance of fecal immunochemical tests (FITs) for colorectal cancer (CRC)

283 BACKGROUND & AIMS: A variety of fecal immunochemical tests (FITs) for hemoglobin (Hb) are used

284 Quantitative fecal immunochemical tests (FITs) for hemoglobin are commonly

285 Quantitative fecal immunochemical tests (FITs) identify individuals with co

286 cer (CRC) screening using quantitative fecal immunochemical tests (FITs) is rapidly gaining ground wo

287 Performance characteristics of fecal immunochemical tests (FITs) to screen for colorectal can

288 We investigated whether 2 quantitative fecal immunochemical tests (FITs) with the same cutoff concent

289 colorectal cancer (CRC), with biennial fecal immunochemical tests (FITs), was initiated in The Nether

290 colorectal cancer (CRC), with biennial fecal immunochemical tests (FITs), was initiated in The Nether

291 ecrease with repeated testing by using fecal immunochemical tests (FITs).

292 Fecal immunochemical tests are moderately sensitive, are highl

293 studies suggested that sensitivity of fecal immunochemical tests for detecting advanced neoplasms co

294 Quantitative faecal immunochemical tests for haemoglobin (FIT), which examin

295 Fecal immunochemical tests for hemoglobin are widely used for

296 om patients with positive results from fecal immunochemical tests in a CRC screening program.

297 Both immunochemical tests used the same anti-total egg white

298 -based stool testing (consistent with Faecal Immunochemical Tests; FIT) or triennial colonoscopy.

299 We present evidence of within strain immunochemical variation of surface polysaccharides in p

300 n the human intestine was investigated using immunochemical, Western blotting, RT-PCR, and short-circ